Replies to post #415169 on NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

Troc, Because to publish without presenting first is basically pharmaceutical malpractice. That is why there is anticipation for SNO.

I am happy to reverse this opinion if anyone can show me a couple examples of blockbusters that have followed that path because there are thousands of examples of the proven pathway. I’ll settle for the needle in the haystack as long as there are a few needles, one or two needles are happenstance.

[MI Dendream]

‘Zero indication’ is not true BTW. LG said on the Big Biz Show that conference presentation would occur in close proximity to TLD release. They never said SNO, so we are left to speculate which, but I don’t recall this public statement ever being corrected. The later omission on the same show did not come across to me as a correction to a different plan, but rather a summary statement that neglected details. Reconfirming a plan to publish at ASM also does not correct this statement, rather in my mind it confirms the statement.

If not SNO, how about they share their timing for their plan for release like every other Biotech. By now, they know whether the first journal they submitted to plans to publish and if they moved on to number 2 it should be to a journal that provides a slam dunk at the highest Impact Score possible, like for example Neurooncology.

[pphmlover]

My point being

If they don’t have this ready for SNO
After all this time yes it’s a BIG
Disappointment !!!!